Search Results - "Ng, Boon Tat"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Immunophenotyping schizophrenia subtypes stratified by antipsychotic response by Li, Yanhui, Ong, Jocelyn Wen Xin, See, Yuen Mei, Yee, Jie Yin, Tang, Charmaine, Zheng, Shushan, Ng, Boon Tat, Lee, Bernett Teck Kwong, Rotzschke, Olaf, Andiappan, Anand Kumar, Lee, Jimmy

    Published in Brain, behavior, and immunity (01-01-2025)
    “…•Schizophrenia patients and healthy controls have immunophenotypic differences.•Differences trend across varying degrees of antipsychotic resistance.•Findings…”
    Get full text
    Journal Article
  2. 2

    Association between sleep quality and domains of quality of life amongst patients with first episode psychosis by Ong, Wei Jie, Tan, Xiao Wei, Shahwan, Shazana, Satghare, Pratika, Cetty, Laxman, Ng, Boon Tat, Tang, Charmaine, Verma, Swapna, Chong, Siow Ann, Subramaniam, Mythily

    Published in Health and quality of life outcomes (29-04-2020)
    “…There is a lack of studies exploring associations between sleep and quality of life (QOL) among patients with schizophrenia who have limited exposure to…”
    Get full text
    Journal Article
  3. 3

    Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in Singapore by Yang, Zixu, Takeuchi, Hiroyoshi, Yee, Jie Yin, See, Yuen Mei, Tang, Charmaine, Ng, Boon Tat, Lee, Jimmy

    Published in Schizophrenia research (01-06-2024)
    “…Clozapine is recognized as the gold standard medication for treatment-resistant schizophrenia. Despite the general recommendation of administering in a divided…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia by Law, Claire, See, Yuen Mei, Yee, Jie Yin, Ng, Boon Tat, Zheng, Charmaine Tang Yu, Lee, Jimmy

    Published in The journal of clinical psychiatry (01-09-2023)
    “…Background: Clozapine is the drug of choice indicated for treatment-resistant schizophrenia (TRS), but delays in initiation and underutilization might have…”
    Get full text
    Journal Article
  6. 6

    Global emotion dysregulation and maladaptive cognitive emotion regulation strategies mediate the effects of severe trauma on depressive and positive symptoms in early non-affective psychosis by Liu, Jianlin, Lim, Matthew Sheng Mian, Ng, Boon Tat, Chong, Siow Ann, Subramaniam, Mythily, Mahendran, Rathi

    Published in Schizophrenia research (01-08-2020)
    “…Previous research has shown that childhood trauma contributes to the onset and maintenance of psychosis. However, few studies have accounted for the effects of…”
    Get full text
    Journal Article
  7. 7

    Association between treatment resistance and cognitive function in schizophrenia by Sun, Jiaqian, Yee, Jie Yin, See, Yuen Mei, Tang, Charmaine, Zheng, Shushan, Ng, Boon Tat, Lee, Jimmy

    Published in Singapore medical journal (01-10-2024)
    “…Treatment-resistant schizophrenia (TRS) affects around 30% of individuals with schizophrenia. About half of the patients with TRS who are treated with…”
    Get full text
    Journal Article
  8. 8

    M215. FACTORS ASSOCIATED WITH CLOZAPINE RESPONSE AND RESISTANCE IN SCHIZOPHRENIA by Lee, Jimmy, Yin Yee, Jie, Mei See, Yuen, Tang, Charmaine, Tat Ng, Boon, Chowbay, Balram, Remington, Gary

    Published in Schizophrenia bulletin (18-05-2020)
    “…Abstract Background Clozapine remains the only antipsychotic with unique efficacy in treatment resistant schizophrenia (TRS). Considerable ongoing research and…”
    Get full text
    Journal Article
  9. 9

    Clozapine Use in First-Episode Psychosis: The Singapore Early Psychosis Intervention Programme (EPIP) Perspective by Tang, Charmaine, Subramaniam, Mythily, Ng, Boon Tat, Abdin, Edimansyah, Poon, Lye Yin, Verma, Swapna K

    Published in The journal of clinical psychiatry (01-11-2016)
    “…Early symptomatic response is pertinent in improving outcomes in first-episode psychosis. One of the ways in which this may be achieved is by reducing…”
    Get full text
    Journal Article
  10. 10

    Metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia by Quek, Yue Feng, See, Yuen Mei, Yee, Jie Yin, Rekhi, Gurpreet, Ng, Boon Tat, Tang, Charmaine, Lee, Jimmy

    Published in Asian journal of psychiatry (01-08-2022)
    “…INTRODUCTIONClozapine use is associated with higher risks of metabolic side effects and cardiovascular diseases (CVD). Thus, this study aims to establish and…”
    Get full text
    Journal Article
  11. 11

    Deconstructing the genetic architecture of treatment-resistant schizophrenia in East Asian ancestry by Lim, Keane, Yee, Jie Yin, See, Yuen Mei, Ng, Boon Tat, Zheng, Shushan, Tang, Charmaine, Lencz, Todd, Lee, Jimmy, Lam, Max

    Published in Asian journal of psychiatry (01-12-2023)
    “…BACKGROUNDTreatment-resistant schizophrenia (TRS) affects a substantial proportion of patients who do not respond adequately to antipsychotic medications, yet…”
    Get full text
    Journal Article
  12. 12

    F224. UTILITY OF SALIVA FOR MONITORING OF CLOZAPINE LEVELS by Lee, Jimmy, Yee, Jie Yin, See, Yuen Mei, Tang, Charmaine, Ng, Boon Tat, Remington, Gary, Chowbay, Balram

    Published in Schizophrenia bulletin (01-04-2018)
    “…Abstract Background Clozapine has specific indication for use in Treatment Resistant Schizophrenia (TRS) with guidelines for therapeutic drug monitoring…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15